Article Information
History
- May 24, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gabriel Balmus1 (gb318{at}cam.ac.uk) (https://www.gurdon.cam.ac.uk/),
- Domenic Pilger1 (d.pilger{at}gurdon.cam.ac.uk) (https://www.gurdon.cam.ac.uk/),
- Julia Coates1 (j.coates{at}gurdon.cam.ac.uk),
- Mukerrem Demir1 (m.demir{at}gurdon.cam.ac.uk),
- Matylda Sczaniecka-Clift1 (m.sczaniecka-clift{at}gurdon.cam.ac.uk),
- Anna Barros2 (ab40{at}sanger.ac.uk),
- Michael Woods2 (mw2{at}sanger.ac.uk),
- Beiyuan Fu2 (bf2{at}sanger.ac.uk),
- Fengtang Yang2 (fy1{at}sanger.ac.uk) (http://www.sanger.ac.uk/science/groups/molecular-cytogenetics),
- Elisabeth Chen2 (ec12{at}sanger.ac.uk),
- Matthias Ostermaier3 (m.ostermaier{at}imb-mainz.de),
- Tatjana Stankovic4 (t.stankovic{at}bham.ac.uk),
- Hannes Ponstingl5 (hp3{at}sanger.ac.uk),
- Mareike Herzog1 (herzmare{at}gmail.com),
- Kosuke Yusa2 (ky1{at}sanger.ac.uk),
- Francisco Munoz-Martinez1 (f.munozmartinez{at}gurdon.cam.ac.uk),
- Stephen T Durant6 (stephen.durant{at}astrazeneca.com),
- Yaron Galanty1 (y.galanty{at}gurdon.cam.ac.uk),
- Petra Beli3 (p.beli{at}imb-mainz.de) (https://www.imb.de/research/beli),
- David J Adams5 (da1{at}sanger.ac.uk),
- Allan Bradley5 (abradley{at}sanger.ac.uk),
- Emmanouil Metzakopian5 (em11{at}sanger.ac.uk),
- Josep V Forment7 (josep.forment{at}astrazeneca.com) (http://www2.gurdon.cam.ac.uk/~jacksonlab/) and
- Stephen Philip P Jackson1,8 (spj13{at}cam.ac.uk) (http://www.gurdon.cam.ac.uk/research/jackson)
- 1 The Wellcome Trust and Cancer Research UK Gurdon Institute, University of Cambridge;
- 2 Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK;
- 3 Institute of Molecular Biology (IMB), 55128 Mainz, Germany;
- 4 Institute of Cancer and Genomic Sciences, University of Birmingham;
- 5 Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.;
- 6 DNA Damage Response Biology, Bioscience Oncology IMED Biotech Unit, AstraZeneca, Cambridge CB4 0WG;
- 7 DNA Damage Response Biology, Bioscience Oncology IMED Biotech Unit, AstraZeneca, Cambridge CB4 0WG,
- ↵* Corresponding author; email: spj13{at}cam.ac.uk